For mild to moderate psoriasis, topical drugs are often preferred due to their localized action and reduced risk of systemic side effects. At Ace Therapeutics, our expertise in preclinical research and development provides the solution for advancing topical antipsoriatic therapies.
Topical therapies remain the first-line treatment for psoriasis due to their targeted action and reduced systemic exposure. These formulations primarily include corticosteroids, vitamin D analogs, retinoids, and novel therapies such as biologics. The effectiveness of these agents is often limited by their ability to penetrate the skin barrier, necessitating advanced drug delivery systems.
Recent advancements have focused on utilizing nanotechnology to improve the bioavailability of active ingredients. Liposomes, solid lipid nanoparticles, and polymeric micelles are some of the innovative systems that enhance skin penetration and localized drug delivery. For instance, studies have shown that liposomal formulations can significantly increase the permeation of corticosteroids through the stratum corneum, leading to improved therapeutic outcomes.
Fig. 1 Schematic illustration of anatomical structure of the human skin and representative novel drug delivery system for the topical treatment of psoriasis. (An P, et al., 2024)
Ace Therapeutics offers a full spectrum of preclinical services tailored to the development of topical antipsoriatic drugs. Our services encompass every preclinical stage of the drug development pipeline, ensuring a streamlined process from concept to preclinical validation.
Our team sssissts in designing and formulating innovative topical therapies utilizing various drug delivery systems. Ace Therapeutics specializes in the screening of advanced topical drug delivery systems tailored to enhance the efficacy of antipsoriatic agents.
We provide comprehensive analytical services that include stability testing, release kinetics, and characterization of the physicochemical properties of formulations. These analyses are crucial for understanding how your samples behave in various environments and evaluating their viability for further development.
Preclinical testing is crucial for assessing the safety and efficacy of topical formulations before advancing to further stages of development.
Ace Therapeutics is dedicated to advancing the development of topical antipsoriatic drugs through comprehensive formulation strategies, rigorous preclinical testing, and a commitment to quality. Contact us today to learn more about how we can support your drug development journey and help you achieve success in the competitive field of psoriasis therapeutics.
Reference